Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results

AbstractObjective:The aim of this study is to assess the efficacy of microablative fractional CO2 laser therapy for genitourinary syndrome of menopause (GSM) management, when three, four, or five laser therapies were applied in a follow-up period of 12 months.Methods:Retrospective study evaluating G